[eBrief] Industry Brief: How Boston Scientific Accelerated Enrollment by 78%

The pressure to get drugs to market faster has increased as the industry faces the constant challenges of rising commercialization costs, tightening competition, and impending patent expirations. Developing new drugs is a long, slow and regulated process yet has the potential to commercialize a new drug that can save lives and grow revenue. By modernizing agreement processes that are everywhere within life sciences companies, life-saving drugs and devices can get to market faster and business processes can be done smarter.


Sponsored by: